Seborrheic Dermatitis Higher in Men, Associated With Fungal, Bacterial Skin Diseases
Seborrheic dermatitis is more prevalent in men and older people and has an increased rate of dermatological comorbidity.
Dermatology
Newly Approved Recombinant Zoster Vaccine Provides Better Value, Lower Costs
The new recombinant zoster vaccine features a lower cost-effectiveness ratio than other recommended adult vaccines.
Unique Presentation of SJS in a Female Patient Treated With TMP-SMX
The patient, who presented to the clinical office complaining of dysuria, was diagnosed with a urinary tract infection and was prescribed TMP-SMX.
Limited Examination Detects Scabies With High Sensitivity
Sensitivity of limited examination is 90%, regardless of scabies severity, presence of impetigo.
Robust Immune Responses for Herpes Zoster Subunit Vaccine
Humoral response seen for 97.8% of HZ/su vaccine recipients vs 2% of placebo.
Guidelines for Preventing Infections in Adolescent Athletes
Many of the recommendations by sports organizations are more stringent than ordinary infection control practices for similar conditions.
Delafloxacin: Tolerable, Effective Against Gram-Negative Pathogens for ABSSSI
Delafloxacin is effective against gram-negative pathogens and has a similar tolerability profile to vancomycin/aztreonam when used in patients with an ASSSSI.
Delafloxacin is Effective, Safe for MRSA Treatment in ABSSSI
Fixed dose delafloxacin IV/oral monotherapy was comparable to vancomycin/aztreonam in patients with ABSSSI and gram-positive pathogens.
No Difference in Adverse Events Between Delafloxacin or Vancomycin/Aztreonam in ABSSSI
Incidence of adverse events with delafloxacin (Baxdela™, Melinta Therapeutics) was comparable to the combination regimen of vancomycin plus aztreonam across 2 phase 3 registrational ABSSSI studies.
Herpes Zoster Risk Greatly Increased in Psoriasis
An increased risk of herpes zoster was found in women, elderly patients, and patients with psoriasis.
